Xilio Therapeutics, Inc. (XLO)
9.00
+0.09
(+1.01%)
USD |
NASDAQ |
Sep 09, 13:58
Xilio Therapeutics Price : 9.00 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 9.03 | 9.11 | 8.81 | 8.91 | 9994.00 |
| Sep 04, 2026 | 9.231 | 9.231 | 8.81 | 9.00 | 7643.00 |
| Sep 03, 2026 | 8.94 | 9.10 | 8.721 | 9.02 | 6571.00 |
| Sep 02, 2026 | 9.142 | 9.142 | 8.84 | 8.84 | 4654.00 |
| Sep 01, 2026 | 8.57 | 9.248 | 8.57 | 8.88 | 31143.00 |
| Aug 31, 2026 | 9.00 | 9.27 | 8.90 | 8.95 | 14571.00 |
| Aug 28, 2026 | 8.995 | 9.28 | 8.995 | 9.00 | 3639.00 |
| Aug 27, 2026 | 8.785 | 9.115 | 8.785 | 9.01 | 9028.00 |
| Aug 26, 2026 | 9.09 | 9.145 | 8.922 | 9.05 | 7709.00 |
| Aug 25, 2026 | 9.16 | 9.30 | 9.08 | 9.08 | 5895.00 |
| Aug 24, 2026 | 9.32 | 9.32 | 9.17 | 9.19 | 2293.00 |
| Aug 21, 2026 | 9.21 | 9.23 | 9.07 | 9.23 | 5225.00 |
| Aug 20, 2026 | 9.27 | 9.27 | 9.110 | 9.23 | 6385.00 |
| Aug 19, 2026 | 9.44 | 9.48 | 9.118 | 9.41 | 6870.00 |
| Aug 18, 2026 | 9.50 | 9.65 | 9.21 | 9.50 | 12987.00 |
| Aug 17, 2026 | 9.07 | 9.90 | 9.07 | 9.49 | 46493.00 |
| Aug 14, 2026 | 9.135 | 9.27 | 8.684 | 9.17 | 8113.00 |
| Aug 13, 2026 | 9.05 | 9.28 | 8.90 | 9.01 | 13380.00 |
| Aug 12, 2026 | 9.18 | 9.18 | 8.781 | 9.05 | 9312.00 |
| Aug 11, 2026 | 9.01 | 9.19 | 9.01 | 9.18 | 6186.00 |
| Aug 10, 2026 | 8.80 | 9.25 | 8.80 | 9.20 | 6551.00 |
| Aug 07, 2026 | 9.40 | 9.40 | 8.88 | 9.17 | 11519.00 |
| Aug 06, 2026 | 9.11 | 9.620 | 9.02 | 9.27 | 34315.00 |
| Aug 05, 2026 | 9.21 | 9.21 | 8.975 | 9.11 | 6090.00 |
| Aug 04, 2026 | 9.165 | 9.24 | 8.975 | 9.09 | 20544.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cue Biopharma, Inc. | 30.90 |
| ACADIA Pharmaceuticals, Inc. | 27.85 |
| Alnylam Pharmaceuticals, Inc. | 254.96 |
| Anika Therapeutics, Inc. | 20.90 |
| Savara, Inc. | 5.405 |
Price Related Metrics
| PS Ratio | 2.067 |
| Price to Book Value | 0.8195 |
| Earnings Yield | -18.73% |
| Market Cap | 59.22M |